SCHEMBL4046163

SCHEMBL4046163

Cc1cc(Nc2nc(S)nc(C(N)=O)c2N)n[nH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AURKA O14965 13/20 0.41
▸ AURKB Q96GD4 11/20 0.41
▸ MEN1 O00255 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ IGF1R P08069 1/20 0.39
▸ FGFR1 P11362 1/20 0.39
▸ KDR P35968 1/20 0.39
▸ PAK4 O96013 2/20 0.39
▸ PLK4 O00444 1/20 0.39
▸ SRC P12931 6/20 0.39
▸ GSK3B P49841 6/20 0.39
▸ AURKC Q9UQB9 1/20 0.38
▸ EIF2AK2 P19525 1/20 0.38
▸ GSK3A P49840 1/20 0.38
▸ CCNA2 P20248 2/20 0.37
▸ CDK2 P24941 2/20 0.37
▸ CCNA1 P78396 2/20 0.37
▸ SYK P43405 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4046155 0.71 MEN1 (0.44) AURKAAURKBMEN1HTTKMT2A
SCHEMBL12105481 0.71 ITK (0.42) AURKAAURKBMEN1HTTKMT2A
SCHEMBL1087829 0.71 AURKB (0.71) AURKAAURKBIGF1RFGFR1KDR
SCHEMBL12105461 0.68 AURKA (0.52) AURKAAURKBMEN1HTTKMT2A
SCHEMBL4005596 0.68 MEN1 (0.59) AURKAAURKBMEN1HTTKMT2A
SCHEMBL28423225 0.67 AURKA (0.44) AURKAAURKBIGF1RFGFR1KDR
SCHEMBL29972030 0.66 CCNA2 (0.58) MEN1KMT2ASRCCCNA2CDK2
SCHEMBL4171606 0.65 AURKA (0.44) AURKAAURKBMEN1HTTKMT2A
SCHEMBL3951464 0.65 IGF1R (0.49) AURKAAURKBMEN1HTTKMT2A
SCHEMBL14657619 0.64 IGF1R (0.64) AURKAAURKBIGF1RPAK4PLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1812424-A4 KINASE INHIBITORS MIIKANA THERAPEUTICS INC (US) 2009-07-08 — — EP disclosed
EP-1812424-A2 KINASE INHIBITORS Miikana Therapeutics, Inc. (US) 2007-08-01 — — EP disclosed
WO-2006055831-A2 KINASE INHIBITORS MIIKANA THERAPEUTICS, INC. (US) 2006-05-26 — — WO disclosed
Send feedback